97 related articles for article (PubMed ID: 21196432)
1. Exploiting tyrosinase expression and activity in melanocytic tumors: quercetin and the central role of p53.
Vargas AJ; Sittadjody S; Thangasamy T; Mendoza EE; Limesand KH; Burd R
Integr Cancer Ther; 2011 Dec; 10(4):328-40. PubMed ID: 21196432
[TBL] [Abstract][Full Text] [Related]
2. Quercetin selectively inhibits bioreduction and enhances apoptosis in melanoma cells that overexpress tyrosinase.
Thangasamy T; Sittadjody S; Lanza-Jacoby S; Wachsberger PR; Limesand KH; Burd R
Nutr Cancer; 2007; 59(2):258-68. PubMed ID: 18001220
[TBL] [Abstract][Full Text] [Related]
3. Tyrosinase overexpression promotes ATM-dependent p53 phosphorylation by quercetin and sensitizes melanoma cells to dacarbazine.
Thangasamy T; Sittadjody S; Limesand KH; Burd R
Cell Oncol; 2008; 30(5):371-87. PubMed ID: 18791269
[TBL] [Abstract][Full Text] [Related]
4. DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progression.
Fürst K; Steder M; Logotheti S; Angerilli A; Spitschak A; Marquardt S; Schumacher T; Engelmann D; Herchenröder O; Rupp RAW; Pützer BM
Cancer Lett; 2019 Feb; 442():299-309. PubMed ID: 30445206
[TBL] [Abstract][Full Text] [Related]
5. Comparison of in vitro cytotoxicity of N-acetyl and N-propionyl derivatives of phenolic thioether amines in melanoma and neuroblastoma cells and the relationship to tyrosinase and tyrosine hydroxylase enzyme activity.
Gili A; Thomas PD; Ota M; Jimbow K
Melanoma Res; 2000 Feb; 10(1):9-15. PubMed ID: 10711635
[TBL] [Abstract][Full Text] [Related]
6. The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-κB inhibition.
Vidya Priyadarsini R; Senthil Murugan R; Maitreyi S; Ramalingam K; Karunagaran D; Nagini S
Eur J Pharmacol; 2010 Dec; 649(1-3):84-91. PubMed ID: 20858478
[TBL] [Abstract][Full Text] [Related]
7. Quercetin attenuates the effects of H2O2 on endoplasmic reticulum morphology and tyrosinase export from the endoplasmic reticulum in melanocytes.
Guan C; Xu W; Hong W; Zhou M; Lin F; Fu L; Liu D; Xu A
Mol Med Rep; 2015 Jun; 11(6):4285-90. PubMed ID: 25625855
[TBL] [Abstract][Full Text] [Related]
8. Improvement of the tumor-suppressive effect of boron neutron capture therapy for amelanotic melanoma by intratumoral injection of the tyrosinase gene.
Morita N; Hiratsuka J; Kondoh H; Uno M; Asano T; Niki Y; Sakurai Y; Ono K; Harada T; Imajo Y
Cancer Res; 2006 Apr; 66(7):3747-53. PubMed ID: 16585201
[TBL] [Abstract][Full Text] [Related]
9. Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers.
Lillehammer T; Tveito S; Engesaeter BO; Fodstad O; Maelandsmo GM; Engebraaten O
Cancer Gene Ther; 2005 Nov; 12(11):864-72. PubMed ID: 15891771
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of tyrosinase expression in canine and equine melanocytic tumors.
Phillips JC; Lembcke LM; Noltenius CE; Newman SJ; Blackford JT; Grosenbaugh DA; Leard AT
Am J Vet Res; 2012 Feb; 73(2):272-8. PubMed ID: 22280389
[TBL] [Abstract][Full Text] [Related]
11. Detection of tyrosinase mRNA from the blood of melanoma patients.
Stevens GL; Scheer WD; Levine EA
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):293-6. PubMed ID: 8722221
[TBL] [Abstract][Full Text] [Related]
12. Quercetin inhibits α-MSH-stimulated melanogenesis in B16F10 melanoma cells.
Yang YM; Son YO; Lee SA; Jeon YM; Lee JC
Phytother Res; 2011 Aug; 25(8):1166-73. PubMed ID: 21290442
[TBL] [Abstract][Full Text] [Related]
13. Effects of latanoprost on tyrosinase activity and mitotic index of cultured melanoma lines.
Dutkiewicz R; Albert DM; Levin LA
Exp Eye Res; 2000 May; 70(5):563-9. PubMed ID: 10870514
[TBL] [Abstract][Full Text] [Related]
14. Sesamin induces melanogenesis by microphthalmia-associated transcription factor and tyrosinase up-regulation via cAMP signaling pathway.
Jiang Z; Li S; Liu Y; Deng P; Huang J; He G
Acta Biochim Biophys Sin (Shanghai); 2011 Oct; 43(10):763-70. PubMed ID: 21896570
[TBL] [Abstract][Full Text] [Related]
15. Characterization of gene regulatory elements for selective gene expression in human melanoma cells.
Artuc M; Nürnberg W; Czarnetzki BM; Schadendorf D
Biochem Biophys Res Commun; 1995 Aug; 213(2):699-705. PubMed ID: 7646526
[TBL] [Abstract][Full Text] [Related]
16. Tyrosinase-related proteins suppress tyrosinase-mediated cell death of melanocytes and melanoma cells.
Rad HH; Yamashita T; Jin HY; Hirosaki K; Wakamatsu K; Ito S; Jimbow K
Exp Cell Res; 2004 Aug; 298(2):317-28. PubMed ID: 15265682
[TBL] [Abstract][Full Text] [Related]
17. Quercetin induces gadd45 expression through a p53-independent pathway.
Yoshida T; Maeda A; Horinaka M; Shiraishi T; Nakata S; Wakada M; Yogosawa S; Sakai T
Oncol Rep; 2005 Nov; 14(5):1299-303. PubMed ID: 16211300
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional targeting of recombinant adenoviruses to human and murine melanoma cells.
Siders WM; Halloran PJ; Fenton RG
Cancer Res; 1996 Dec; 56(24):5638-46. PubMed ID: 8971169
[TBL] [Abstract][Full Text] [Related]
19. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53.
Bush JA; Cheung KJ; Li G
Exp Cell Res; 2001 Dec; 271(2):305-14. PubMed ID: 11716543
[TBL] [Abstract][Full Text] [Related]
20. Tyrosinase activity and isoenzyme distribution corresponding to growth and regression of melanoma in Sinclair miniature swine.
Kovacs SA; Geekie KM; Oxenhandler RW; Agris PF
J Natl Cancer Inst; 1981 Sep; 67(3):645-51. PubMed ID: 6792414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]